Loading organizations...
Wakefield Venture Group offers comprehensive financial services, delivering tailored wealth management strategies to individuals and families. The firm constructs customized programs focusing on growing, preserving, and conserving client wealth, emphasizing a high level of personalized service and experience. They leverage their expertise to guide clients through complex financial landscapes, ensuring bespoke solutions for long-term financial success.
The firm appears to be built on a family foundation, with Chris Wakefield prominently featured among the team members, alongside other individuals sharing the Wakefield surname. This structure suggests an ethos rooted in enduring relationships and a commitment to generational service, though specific founding dates or the precise initial insight driving the firm's inception are not detailed. Their approach stresses a dedicated, hands-on methodology to financial guidance.
Wakefield Venture Group primarily serves clients seeking sophisticated wealth management and financial guidance to navigate life's transitions and achieve enduring financial security. The company's overarching vision is to set a higher standard for wealth management, consistently acting in clients' best interests to help them realize their long-term financial aspirations and foster a trusted, family-like partnership.
Wakefield Group has 2 tracked investments across 2 companies. The latest tracked deal is $25.0M Series A in Envisia Therapeutics in November 2013.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Nov 1, 2013 | Envisia Therapeutics | $25.0M Series A | — | Canaan Partners, Canaan Partners, Morningside, NEW Enterprise Associates, Pappas Ventures |
| Jun 24, 2008 | rPath | $10.0M Series C | General Catalyst, North Bridge, Wakefield Group | — |